Diet, H pylori infection and gastric cancer: Evidence and controversies
Alba Rocco;Gerardo Nardone

..............page:2901-2912

Useful detection of CD147 (EMMPRIN) for pathological diagnosis of early hepatocellular carcinoma in needle biopsy samples
Satoshi Mamori;Keisuke Nagatsuma;Tomokazu Matsuura;Kiyoshi Ohkawa;Hiroshi Hano;Masaharu Fukunaga;Masato Matsushima;Yoshifumi Masui;Nao Fushiya;Hiroshi Onoda;Yasuyuki Searashi;Ichiro Takagi;Hisao Tagiri

..............page:2913-2917

Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: The first pediatric study
Maria Elzbieta Sobaniec-Lotowska;Joanna Maria Lotowska;Dariusz Marek Lebensztejn

..............page:2918-2922

CagA+ H pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis
Shu-Kui Wang;Hui-Fang Zhu;Bang-Shun He;Zhen-Yu Zhang;Zhi-Tan Chen;Zi-Zheng Wang;Guan-Ling Wu

..............page:2923-2931

Leptin treatment ameliorates acute lung injury in rats with cerulein-induced acute pancreatitis
Fatma Ayca Gultekin;Mustafa Kerem;Ertan Tatlicioglu;Aysel Aricioglu;Cigdem Unsal;Neslihan Bukan

..............page:2932-2938

Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis
Yoshihiro Miyanaka;Yoshitaka Ueno;Shinji Tanaka;Kyoko Yoshioka;Tsuyoshi Hatakeyama;Masaru Shimamoto;Masaharu Sumii;Kazuaki Chayama

..............page:2939-2944

Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer
P(a)lvi Vento;Harri Mustonen;Timo Joensuu;P(a)ivi K(a)rkk(a)inen;Eero Kivilaakso;Tuula Kiviluoto

..............page:2945-2951

Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma
Roberto Miraglia;Giada Pietrosi;Luigi Maruzzelli;Ioannis Petridis;Settimo Caruso;Gianluca Marrone;Giuseppe Mamone;Giovanni Vizzini;Angelo Luca;Bruno Gridelli

..............page:2952-2955

Frequency of primary iron overload and HFE gene mutations (C282Y, H63D and S65C) in chronic liver disease patients in north India
Barjinderjit Kaur Dhillon;Reena Das;Gurjeewan Garewal;Yogesh Chawla;RK Dhiman;Ashim Das;Ajay Duseja;GR Chandak

..............page:2956-2959

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease
Martin JW Meijer;Marij AC Mieremet-Ooms;Ruud A van Hogezand;Cornelis BHW Lamers;Daniel W Hommes;Hein W Verspaget

..............page:2960-2966

Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile
Arnoldo Riquelme;Alejandro Soza;Cesar Pedreros;Andrea Bustamante;Felipe Valenzuela;Francisco Otarola;Eduardo Abbott;Narco Arellano;Brenda Medina;Alejandro Pattillo;Douglas Greig;Marco Arrese;Antonio Rollan

..............page:2967-2972

Comparison of postpolypectomy bleeding between epinephrine and saline submucosal injection for large colon polyps by conventional polypectomy: A prospective randomized, multicenter study
Suck-Ho Lee;Il-Kwun Chung;Sun-Joo Kim;Jin-Oh Kim;Bong-Min Ko;Won Ho Kim;Hyun-Soo Kim;Dong-IL Park;Hyo-Jong Kim;Jeong-Sik Byeon;Suk-Kyun Yang;Byeong Ik Jang;Sung-Ae Jung;Yoon-Tae Jeen;Jai-Hyun Choi;Hwang Choi;Dong-Soo Han;Jae Suk Song

..............page:2973-2977

Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density
T Karakan;O Ozyemisci-Taskiran;Z Gunendi;F Atalay;C Tuncer

..............page:2978-2982

H pylori infection in patients with Behcet's disease
Osman Ersoy;Reyhan Ersoy;Ozlem Yayar;Huseyin Demirci;Semih Tatlican

..............page:2983-2985

Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma
Ubol Chuensumran;Sopit Wongkham;Chawalit Pairojkul;Siri Chauin;Songsak Petmitr

..............page:2986-2991

Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021
Shi-Hai Xia;Chun-Xiu Hu;Zhi-Ling Zhao;Guo-Dong Xia;Yao Di

..............page:2992-2998

Comparison scoring model of severe viral hepatitis and model of end stage liver disease for the prognosis of patients with liver failure in China
Li Zhou;Pei-Ling Dong;Hui-Guo Ding

..............page:2999-3002

Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy
Zhi-Jun Bao;De-Kai Qiu;Xiong Ma;Zhu-Ping Fan;Gan-Sheng Zhang;Yi-Qin Huang;Xiao-Feng Yu;Min-De Zeng

..............page:3003-3008

Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers
Jun-Jie Peng;San-Jun Cai;Hong-Feng Lu;Guo-Xiang Cai;Peng Lian;Zu-Qing Guan;Ming-He Wang;Ye Xu

..............page:3009-3015

Complete eradication of hepatic metastasis from colorectal cancer by Yttrium-90 SIRT
Sean Garrean;Amanda Muhs;James T Bui;Michael J Blend;Charles Owens;William S Helton;N Joseph Espat

..............page:3016-3019

Hepatitis C virus RNA kinetics: Drug efficacy and the rate of HCV-infected cells loss
Harel Dahari;Alan S Perelson

..............page:3020-3021

Instructions to authors

..............page:3024-3026